Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease

Journal of Rheumatology

Volumn 39, Issue 6, 2012, Pages 1265-1274

  Rajaram, Smitha ^a,b   Swift, Andrew James ^a   Capener, David ^a   Elliot, Charles A ^c   Condliffe, Robin ^c   Davies, Christine ^b   Hill, Catherine ^b   Hurdman, Judith ^c   Kidling, Rachael ^b   Akil, Mohammed ^b   Wild, Jim M ^a   Kiely, David G ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Connective tissue disease; Magnetic resonance imaging; Pulmonary arterial hypertension; Survival; Systemic sclerosis

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART DISEASE; HEART FUNCTION; HEART INDEX; HEART RIGHT CATHETERIZATION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE MASS; HEART VENTRICLE; HEART VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LEFT AND RIGHT VENTRICULAR DIAMETER RATIO; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN SIZE; POSITION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY AORTIC RATIO; PULMONARY ARTERY SIZE; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; SYSTOLE; TRICUSPID GRADIENT; TRICUSPID VALVE REGURGITATION; VENTRICULAR MASS INDEX;

CONNECTIVE TISSUE DISEASES; ECHOCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY ARTERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861818988     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110987     Document Type: Article

References (41)

1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4. (Pubitemid 46999798)
2. Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (The UNCOVER Study). Arthritis Rheum 2005;52:2125-32. (Pubitemid 40994336)
3. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009;179:151-7.
4. Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54:3043-50. (Pubitemid 44497786)
5. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, et al. Aspire Registry: Assessing the spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 2011 Sep 8 (E-pub ahead of print).
6. Ley S, Grunig E, Kiely DG, van Beek E, Wild J. Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle. J Magn Reson Imaging 2010;32:1313-24.
7. Alunni JP, Degano B, Arnaud C, Tetu L, Blot-Souletie N, Didier A, et al. Cardiac MRI in pulmonary artery hypertension: Correlations between morphological and functional parameters and invasive measurements. Eur Radiol 2010;20:1149-59.
8. Ley S, Mereles D, Puderbach M, Gruenig E, Schock H, Eichinger M, et al. Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol 2007;17:1892-7. (Pubitemid 46909681)
9. Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, et al. Pulmonary hypertension: Accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007;243:63-9. (Pubitemid 46579695)
10. Roeleveld RJ, Marcus JT, Boonstra A, Postmus PE, Marques KM, Bronzwaer JG, et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005;22:67-72. (Pubitemid 40885130)
11. Elliot C, Kiely DG. Pulmonary hypertension: Diagnosis and treatment. Clin Med 2004;4:211-5. (Pubitemid 38856534)
12. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
15. Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. Chest 1998;113:1250-6. (Pubitemid 28223812)
16. Reid JH, Murchison JT. Acute right ventricular dilatation: A new helical CT sign of massive pulmonary embolism. Clin Radiol 1998;53:694-8. (Pubitemid 28431979)
17. Groves AM, Win T, Charman SC, Wisbey C, Pepke-Zaba J, Coulden RA. Semi-quantitative assessment of tricuspid regurgitation on contrast-enhanced multidetector CT. Clin Radiol 2004;59:715-9. (Pubitemid 39022769)
18. Bezante GP, Rollando D, Sessarego M, Panico N, Setti M, Filaci G, et al. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol 2007;34:2431-7. (Pubitemid 350230667)
19. Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology 2009;48:1137-42.
20. Kind T, Mauritz GJ, Marcus JT, van de Veerdonk M, Westerhof N, Vonk-Noordegraaf A. Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson 2010;12:35.
21. Jardim C, Rochitte CE, Humbert M, Rubenfeld G, Jasinowodolinski D, Carvalho CR, et al. Pulmonary artery distensibility in pulmonary arterial hypertension: An MRI pilot study. Eur Respir J 2007;29:476-81. (Pubitemid 46372093)
22. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54 Suppl:S43-54.
23. Condliffe R, Radon M, Hurdman J, Davies C, Hill C, Akil M, et al. CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology 2011;50:1480-6.
24. Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997;36:239-43.
25. Mukerjee D, St. George D, Knight C, Davar J, Wells AU, Du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:461-6. (Pubitemid 38489363)
26. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008;35:458-65. (Pubitemid 351374421)
27. Busteed S, Moots RJ, Thompson RN. Screening for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:1315-6; reply 6.
28. Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009;60:1831-9.
29. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-7. (Pubitemid 47343830)
30. Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002;20:1519-24. (Pubitemid 35460622)
31. Nijveldt R, Germans T, McCann GP, Beek AM, van Rossum AC. Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: A cardiovascular magnetic resonance study. Eur Radiol 2008;18:2399-405.
32. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006;45 Suppl 4:iv14-7. (Pubitemid 44446757)
33. Bradlow WM, Assomull R, Kilner PJ, Gibbs JS, Sheppard MN, Mohiaddin RH. Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging 2010;3:501-3.
34. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: A delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36. (Pubitemid 350100715)
35. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-21.
36. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344-50. (Pubitemid 36269414)
37. Gan CT, Lankhaar JW, Westerhof N, Marcus JT, Becker A, Twisk JW, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007;132:1906-12.
38. Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249:1042-9.
39. Tunon J, Cordoba M, Rey M, Almeida P, Rabago R, Sanchez-Cascos A, et al. Assessment of chronic tricuspid regurgitation by colour Doppler echocardiography: A comparison with angiography in the catheterization room. Eur Heart J 1994;15:1074-84. (Pubitemid 24266372)
40. Revel MP, Faivre JB, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology 2009;250:558-66.
41. Meune C, Avouac J, Airo P, Beretta L, Dieude P, Wahbi K, et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011;63:2790-6.